NasdaqGS - Delayed Quote USD

DBV Technologies S.A. (DBVT)

0.6800 +0.0200 (+3.03%)
At close: April 23 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
76,533.0000
76,533.0000
96,631.0000
99,535.0000
135,292.0000
Operating Income
-76,533.0000
-76,533.0000
-96,631.0000
-99,535.0000
-135,292.0000
Net Non Operating Interest Income Expense
3,714.0000
3,714.0000
427.0000
425.0000
-724.0000
Other Income Expense
--
--
--
920.0000
-23,552.0000
Pretax Income
-72,719.0000
-72,719.0000
-96,204.0000
-98,189.0000
-159,566.0000
Tax Provision
7.0000
7.0000
70.0000
-381.0000
-10.0000
Net Income Common Stockholders
-72,726.0000
-72,726.0000
-96,274.0000
-97,809.0000
-159,555.0000
Diluted NI Available to Com Stockholders
-72,726.0000
-72,726.0000
-96,274.0000
-97,809.0000
-159,555.0000
Basic EPS
-0.55
-0.38
-0.62
-0.89
-1.48
Diluted EPS
-0.55
-0.38
-0.62
-0.89
-1.48
Basic Average Shares
189,301.2620
190,242.7800
155,322.5810
109,833.8740
108,185.3320
Diluted Average Shares
189,301.2620
190,242.7800
155,322.5810
109,833.8740
108,185.3320
Total Operating Income as Reported
-76,432.0000
-76,432.0000
-96,631.0000
-98,614.0000
-158,842.0000
Rent Expense Supplemental
--
--
--
--
1,064.0000
Total Expenses
76,533.0000
76,533.0000
96,631.0000
99,535.0000
135,292.0000
Net Income from Continuing & Discontinued Operation
-72,726.0000
-72,726.0000
-96,274.0000
-97,809.0000
-159,555.0000
Normalized Income
-72,726.0000
-72,726.0000
-96,274.0000
-98,725.4120
-136,004.4760
Interest Expense
--
--
--
--
724.0000
Net Interest Income
3,714.0000
3,714.0000
427.0000
425.0000
-724.0000
EBIT
-76,533.0000
-76,533.0000
-96,631.0000
-99,535.0000
-135,292.0000
EBITDA
-67,372.0000
-67,372.0000
-83,469.0000
-86,316.0000
-122,800.0000
Reconciled Depreciation
-13,998.0000
-13,998.0000
13,162.0000
8,376.0000
10,461.0000
Net Income from Continuing Operation Net Minority Interest
-72,726.0000
-72,726.0000
-96,274.0000
-97,809.0000
-159,555.0000
Total Unusual Items Excluding Goodwill
--
--
--
920.0000
-23,552.0000
Total Unusual Items
--
--
--
920.0000
-23,552.0000
Normalized EBITDA
-67,372.0000
-67,372.0000
-83,469.0000
-87,236.0000
-99,248.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
0.0000
Tax Effect of Unusual Items
--
--
--
3.5880
-1.4760
12/31/2020 - 10/22/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DSGN Design Therapeutics, Inc.
3.6600
-5.91%
 
ALVR AlloVir, Inc.
0.7909
+3.66%
 
BOLT Bolt Biotherapeutics, Inc.
1.1100
0.00%
 
BCTXW BriaCell Therapeutics Corp.
0.9100
-3.07%
 
CYAD.BR Celyad Oncology SA
0.3300
+3.13%
 
ENTA Enanta Pharmaceuticals, Inc.
13.15
-2.16%
 
SNTI Senti Biosciences, Inc.
0.3000
+6.80%
 
TFFP TFF Pharmaceuticals, Inc.
2.9700
+13.79%
 
TCRX TScan Therapeutics, Inc.
7.26
+1.97%
 
PASG Passage Bio, Inc.
1.2300
+7.89%